Do you know how much drug Genzyme has available if this production process is not approved? i.e. will they have to turn down some of the older (heavier) patients?
>Wonder if the current FDA look at Genzyme myozyme for Pompe's disease will give us some insight into their view of biosimiliars.<
Unfortunately for us, the part of Tuesday’s Myozyme advisory panel that deals with manufacturing is being conducted behind closed doors to protect GENZ’s trade secrets.
<font size=3><font color=red> “The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Market Data 
Markets 
AI
